MRX-502: Randomized Double-blind Placebo-controlled Phase 3 Study to Evaluate the Efficacy and Safety of Maralixibat in the Treatment of Subjects With Progressive Familial Intrahepatic Cholestasis (PFIC) - MARCH-PFIC (2023)
Also books, you know, were both authors that we can really connect with people on the subject matter beyond your realm of patients in Dallas, you can share your ideas in this form, which is really exciting, I think
View Abstract [15] de Souza-Pinto NC, Eide L, Hogue BA, Thybo T, Stevnsner T, Seeberg E, Klungland A, Bohr VA
Birsoy, K
Using a carefully curated combination of vitamins and minerals, the treatment enhances fat metabolism, boosts energy levels, and supports detoxification for improved overall health